Wordt geladen...
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) have emerged as a dominant T cell population inhibiting anti-tumor effector T cells. Initial strategies used for Treg-depletion (cyclophosphamide, anti-CD25 mAb…) also targeted activated T cells, as they share many phenotypic markers. Current, ameliora...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Landes Bioscience
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382865/ https://ncbi.nlm.nih.gov/pubmed/22737608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.18852 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|